
News
Home>News & Events>Publications>C-Path>Coalition Against Major Diseases/European Medicines Agency Biomarker Qualification Of Hippocampal Volume For Enrichment Of Clinical Trials In Predementia Stages Of Alzheimer’s Disease
86,57
Related Posts
-
Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease
-
The Future Is Now: Model‐based Clinical Trial Design For Alzheimer’s Disease
-
Development Of A Unified Clinical Trial Database For Alzheimer’s Disease
-
Charting A Path Toward Combination Therapy For Alzheimer’s Disease
-
Modeling And Simulation For Medical Product Development And Evaluation: Highlights From The FDA-C-Path-ISOP 2013 Workshop